Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis

Acta Neurologica Scandinavica

Volumn 138, Issue 2, 2018, Pages 104-114

  Yang, Tao ^a   Li, Zhiqiang ^b   Jiang, Li ^a   Wang, Yinhua ^b   Xi, Xiuming ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

critical illness; intensive care unit acquired weakness; risk factors; systematic review

Indexed keywords

AMINOGLYCOSIDE; CORTICOSTEROID; LACTIC ACID; NEUROMUSCULAR BLOCKING AGENT; NORADRENALIN;

ADULT; AGE; APACHE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; ELECTROLYTE DISTURBANCE; HUMAN; HYPERGLYCEMIA; HYPEROSMOLARITY; INTENSIVE CARE UNIT; META ANALYSIS; MULTIPLE ORGAN FAILURE; PARENTERAL NUTRITION; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SEPSIS; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEAKNESS; CHINA; CRITICAL ILLNESS; FEMALE; MUSCLE WEAKNESS; PROSPECTIVE STUDY;

ADULT; CHINA; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MUSCLE WEAKNESS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85047778349     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12964     Document Type: Review

References (53)

1. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33:1876-1891.
2. Appleton RT, Kinsella J, Quasim T. The incidence of intensive care unit-acquired weakness syndromes: A systematic review. J Intensive Care Soc. 2014;16:126-136.
3. Hermans G, van Mechelen H, Clerckx B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190:410-420.
4. Nguyen THE L, Nguyen Huu C. Critical illness polyneuropathy and myopathy in a rural area in Vietnam. J Neurol Sci. 2015;357:276-281.
5. Penuelas O, Muriel A, Frutos-Vivar F, et al. Prediction and outcome of intensive care unit-acquired paresis. J Intensive Care Med. 2018;33:16-28.
6. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299-S308.
7. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384.
8. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
9. Mallett S, Royston P, Dutton S, Waters R, Altman DG. Reporting methods in studies developing prognostic models in cancer: a review. BMC Med. 2010;8:20.
10. Gupta S, Mishra M. Acute Physiology and Chronic Health Evaluation II score of >/=15: a risk factor for sepsis-induced critical illness polyneuropathy. Neurol India. 2016;64:640-645.
11. Wieske L, Witteveen E, Verhamme C, et al. Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study. PLoS ONE. 2014;9:e111259.
12. Patel BK, Pohlman AS, Hall JB, Kress JP. Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated. Chest. 2014;146:583-589.
13. Parsons EC, Kross EK, Ali NA, et al. Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilation. J Crit Care. 2013;28:1079-1085.
14. Hermans G, Casaer MP, Clerckx B, et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med. 2013;1:621-629.
15. Weber-Carstens S, Deja M, Koch S, et al. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care. 2010;14:R119.
16. Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med. 2010;36:66-74.
17. Nanas S, Kritikos K, Angelopoulos E, et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand. 2008;118:175-181.
18. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007;175:480-489.
19. van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64:1348-1353.
20. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252:343-351.
21. de Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859-2867.
22. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27:1288-1296.
23. Novak KR, Nardelli P, Cope TC, et al. Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest. 2009;119:1150-1158.
24. Latronico N, Shehu I, Guarneri B. Use of electrophysiologic testing. Crit Care Med. 2009;37:S316-S320.
25. Eikermann M, Koch G, Gerwig M, et al. Muscle force and fatigue in patients with sepsis and multiorgan failure. Intensive Care Med. 2006;32:251-259.
26. Gordon BS, Kelleher AR, Kimball SR. Regulation of muscle protein synthesis and the effects of catabolic states. Int J Biochem Cell Biol. 2013;45:2147-2157.
27. Aversa Z, Alamdari N, Castillero E, Muscaritoli M, Rossi Fanelli F, Hasselgren PO. CaMKII activity is reduced in skeletal muscle during sepsis. J Cell Biochem. 2013;114:1294-1305.
28. Druschky A, Herkert M, Radespiel-Troger M, et al. Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med. 2001;27:686-693.
29. Finfer S, Chittock DR, Su SY, et al. Intensive vs conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
30. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-1062.
31. Jaber S, Petrof BJ, Jung B, et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011;183:364-371.
32. Hermans G, Agten A, Testelmans D, Decramer M, Gayan-Ramirez G. Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care. 2010;14:R127.
33. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005;33:349-354.
34. de Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30:1117-1121.
35. Eikermann M, Groeben H, Husing J, Peters J. Predictive value of mechanomyography and accelerometry for pulmonary function in partially paralyzed volunteers. Acta Anaesthesiol Scand. 2004;48:365-370.
36. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304-377.
37. Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671-1684.
38. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131:954-963.
39. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve. 1992;15:1290-1298.
40. Aare S, Radell P, Eriksson LI, et al. Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model. Physiol Genomics. 2013;45:312-320.
41. Mueller N, Murthy S, Tainter CR, et al. Can sarcopenia quantified by ultrasound of the rectus femoris muscle predict adverse outcome of surgical intensive care unit patients as well as frailty? a prospective, Observational Cohort Study. Ann Surg. 2016;264:1116-1124.
42. Goiburu ME, Goiburu MM, Bianco H, et al. The impact of malnutrition on morbidity, mortality and length of hospital stay in trauma patients. Nutr Hosp. 2006;21:604-610.
43. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310:1591-1600.
44. Casaer MP, Mesotten D, Hermans G, et al. Early vs late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506-517.
45. Artinian V, Krayem H, Digiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006;129:960-967.
46. Minard G, Kudsk KA, Melton S, Patton JH, Tolley EA. Early vs delayed feeding with an immune-enhancing diet in patients with severe head injuries. JPEN J Parenter Enteral Nutr. 2000;24:145-149.
47. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med. 2001;29:2264-2270.
48. Alhazzani W, Alshahrani M, Jaeschke R, et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17:R43.
49. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107-1116.
50. Berg DK, Hall ZW. Increased extrajunctional acetylcholine sensitivity produced by chronic acetylcholine sensitivity produced by chronic post-synaptic neuromuscular blockade. J Physiol. 1975;244:659-676.
51. Testelmans D, Maes K, Wouters P, et al. Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med. 2006;34:3018-3023.
52. Price DR, Mikkelsen ME, Umscheid CA, Armstrong EJ. Neuromuscular blocking agents and neuromuscular dysfunction acquired in critical illness: a systematic review and meta-analysis. Crit Care Med. 2016;44:2070-2078.
53. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.